Results Using Base-Case MESA Event Rates.

Note: A risk assessment and treatment strategy is said to dominate if it is less costly and more effective than both of the alternative strategies to which it is compared. Otherwise, the favored strategy may be incrementally more costly and more effective than ATP III, which was the standard of risk assessment when this study was conducted. If the incremental cost per unit of effect is less than or equal to $50,000, but positive, the alternative intervention is assumed to be favored, and an incremental cost-effectiveness ratio (ICER) is reported. If the ICER exceeds $50,000, ATP III is preferred. Mean costs and effects for each strategy, which are the basis for the decisions summarized in the table, are presented in S2 Table. Scenarios are identified by the scenario number on each row of the table.
Results Using Base-Case MESA Event Rates.